EDISON INTERNATIONAL financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data EDISON INTERNATIONAL files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	11,869	12,320	12,657	12,347	13,578	14,905	17,220	16,338	17,599	19,317
Operating income	2,062	1,456	-552	1,775	1,217	1,477	1,483	2,627	2,930	7,093
Interest expense	581	639	734	841	902	925	1,169	1,612	1,869	1,539
Other non-operating income	109	132	197	193	251	237	348	500	502	438
Pre-tax income		949	-1,089	1,127	566	789	662	1,515	1,563	5,992
Income tax	177	281	-739	-278	-305	-136	-162	108	17	1,291
Income from continuing operations	1,299	565	-457	1,284	739
Net income to minority interests	-9	-21	-14	0	0
Net income	1,311	565	-423	1,284	739	759	612	1,197	1,284	4,459
EBITDA	4,160	3,571	1,388	3,578	3,246	3,765	4,116	5,262	5,796	10,330
EPS, basic	4.02	1.73	-1.30	3.78	1.98	2.00	1.61	3.12	3.33	11.58
EPS, diluted	3.97	1.72	-1.30	3.77	1.98	2.00	1.60	3.11	3.31	11.55
Shares, basic (weighted)	326	326	326	340	373	380	381	383	386	385
Shares, diluted (weighted)	330	328	326	341	374	380	383	385	388	386
Dividend per share	1.98	2.23	2.43	2.48	2.58	2.69	2.84	2.99	3.17	3.36

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	96	1,091	144	68	87	390	914	345	193	158
Receivables	714	717	730	788	1,130	1,398	1,695	2,016	2,169	1,463
Inventory	239	242	282	364	405	420	474	527	538	535
Other current assets	177	202	78	188	292	249	397	341	418	745
Total current assets	2,123	3,729	3,359	3,560	5,061	5,491	7,070	6,811	7,155	7,686
Property, plant and equipment	37,000	39,050	41,348	44,285	47,839	50,700	53,486	56,084	59,254	63,328
Lease right-of-use assets			0	693	1,088	1,932	1,442	1,221	1,180	1,161
Long-term investments						12	5	4,227	4,343	4,586
Other non-current assets	416	374	2,445	648	860	1,485	1,239	2,062	2,403	2,168
Total assets	51,319	52,580	56,715	64,382	69,372	74,745	78,041	81,758	85,579	94,026
Accounts payable	1,342	1,503	1,511	1,752	1,980	2,002	2,359	1,983	2,000	2,344
Accrued liabilities								390	422	473
Short-term debt	981	481	79	479	1,029	1,077	2,614	2,697	2,049	1,928
Total current liabilities	5,912	7,068	5,395	5,523	10,277	8,609	10,347	8,598	8,439	10,536
Long-term debt	10,175	11,642	14,632	17,864	19,632	24,170	27,025	30,316	33,534	36,070
Lease liabilities			0	613	873	1,350	936	1,101	1,056	1,041
Other non-current liabilities	2,102	2,953	2,562	3,152	2,910	3,105	2,988	3,258	3,566	3,705
Total liabilities	37,127	38,695	44,063	48,886	53,423	56,956	60,519	63,814	67,839	74,767
Total debt	11,156	12,123	14,711	18,343	20,337	25,247	29,639	33,013	35,583	37,998
Paid-in capital	2,505	2,526	2,545	4,990	5,962	6,071	6,200	6,338	6,353	6,362
Retained earnings	9,544	9,188	7,964	8,382	8,155	7,894	7,454	7,499	7,567	10,714
Other comprehensive income	-53	-43	-50	-69	-69	-54	-11	-9	0	6
Shareholders' equity					14,048	15,888	15,621	15,501	15,565	17,579
Minority interests	0	2	0
Total equity	14,187	13,866	12,652	15,496	15,949	17,789	17,522	17,944	17,740	19,259
Total liabilities and equity	51,319	52,580	56,715	64,382	69,372	74,745	78,041	81,758	85,579	94,026
Shares outstanding	326	326	326	362	379	380	382	384	385	385

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	1,425	668	-316	1,405	871	925	824	1,407	1,546	4,701
Depreciation and amortization	2,098	2,115	1,940	1,803	2,029	2,288	2,633	2,635	2,866	3,237
Stock-based compensation	34	23	21	29	29	39	42	46	57	57
Deferred income tax	190	498	-527	-284	-296	43	-177	108	9	1,233
Change in receivables	50	6	-39	-76	-283	-514	-252	-349	-278	662
Change in inventory	8	-12	-49	-83	-43	-21	-58	-63	-14	-4
Change in payables	35	50	-31	288	87	138	367	-408	53	78
Cash from operations	3,254	3,597	3,177	-307	1,263	11	3,216	3,401	5,014	5,800
Capital expenditures	-3,749	-3,844	-4,509	-4,877	-5,484	-5,505	-5,778	-5,448	-5,707	-6,515
Cash from investing	-3,403	-3,586	-4,239	-4,678	-4,971	-5,151	-5,574	-5,233	-5,536	-6,335
Debt issued	397	2,233	3,237	3,696	3,073	5,412	5,971	5,121	5,256	5,133
Debt repaid	-220	-1,285	-654	-82	-1,099	-1,037	-1,085	-2,498	-2,701	-2,052
Stock issued	135	0	0	2,391	912	32	13	20
Share buybacks							0	0	-200	-32
Dividends paid	-626	-707	-788	-810	-928	-988	-1,050	-1,112	-1,198	-1,274
Cash from financing	95	1,007	82	4,903	3,727	5,445	2,881	1,447	674	571
Net change in cash	-65	1,018	-980	-82	19	305	523	-385	152	36
Free cash flow	-495	-247	-1,332	-5,184	-4,221	-5,494	-2,562	-2,047	-693	-715
Interest paid	504	548	595	705	836	887	1,001	1,401	1,588	1,716
Income taxes paid	18	1	-135	-85	-34	-88	-49	0	51

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2026; growth uses fiscal years. Valuation uses the share price of $52.65 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	30.8%	Operating income / revenue.
EBITDA margin	47.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	24.1%	Pre-tax income / revenue.
Net margin	18.1%	Net income / revenue.
FCF margin	-3.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	30.6%	Cash from operations / revenue.
Effective tax rate	20.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	20.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	3.8%	Net income / average total assets.
Return on invested capital (ROIC)	8.4%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Capex / revenue	33.9%	Capital expenditures / revenue.
D&A / revenue	17.0%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	9.8%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	3.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	7.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	142.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	68.5%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	42.3%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	78.2%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	35.9%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	26.1%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	247.3%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	93.9%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	43.3%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	248.9%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	93.3%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	42.3%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	15.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	21.7%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	35.6%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	6.1%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	5.8%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	5.5%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	12.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	4.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	4.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	9.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	6.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	6.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.6%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.74x	Current assets / current liabilities.
Quick ratio	0.18x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.02x	(Cash + short-term investments) / current liabilities.
Debt / equity	2.33x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	42.7%	Total debt / total assets.
Liabilities / assets	80.0%	Total liabilities / total assets.
Net debt	$40.14B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	4.29x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	3.42x	Operating income / interest expense.
Working capital	-$2.52B	Current assets - current liabilities.
Tangible book value	$17.32B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.21x	Revenue / average total assets.
Fixed asset turnover	0.31x	Revenue / average property, plant and equipment.
Receivables turnover	12.4x	Revenue / average receivables.
Days sales outstanding	29 days	365 x average receivables / revenue.
FCF conversion	-18.1%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	110.7%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$9.18	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$50.67	Revenue / diluted weighted shares.
FCF per share	-$1.66	Free cash flow / diluted weighted shares.
Operating cash flow per share	$15.51	Cash from operations / diluted weighted shares.
Book value per share	$45.01	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$45.01	Tangible book value / shares outstanding.
Cash per share	$0.44	(Cash + short-term investments) / shares outstanding.
Payout ratio	36.4%	Dividends paid / net income, when net income is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$20.26B	Share price x shares outstanding.
Enterprise value	$60.40B	Market cap + total debt - cash - short-term investments.
P/E	5.70x	Market cap / net income. Only when net income is positive.
P/S	1.03x	Market cap / revenue.
P/B	1.17x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.17x	Market cap / tangible book value, when positive.
P/OCF	3.38x	Market cap / cash from operations, when positive.
EV/Sales	3.08x	Enterprise value / revenue.
EV/EBIT	10.0x	Enterprise value / operating income, when both are positive.
EV/EBITDA	6.45x	Enterprise value / EBITDA, when both are positive.
FCF yield	-3.2%	Free cash flow / market cap.
Earnings yield	17.5%	Net income / market cap (the inverse of P/E).
Dividend yield	6.4%	Dividends paid over the period / market cap.
Shareholder yield	6.5%	(Dividends paid + share buybacks) / market cap.
PEG	0.06x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was EDISON INTERNATIONAL's revenue in fiscal 2025?

EDISON INTERNATIONAL reported revenue of $19.32B for fiscal 2025, 9.8% higher than the year before.

Was EDISON INTERNATIONAL profitable in fiscal 2025?

Yes. Net income was $4.46B, a net margin of 23.1%.

How much free cash flow did EDISON INTERNATIONAL generate in fiscal 2025?

Cash from operations of $5.80B minus capital expenditures of $6.52B left free cash flow of -$715.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to EDISON INTERNATIONAL